Patents
Patents for C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof (5,273)
11/2008
11/18/2008US7452992 Heterocyclic compounds as CCR5 antagonists
11/13/2008WO2008008376A3 Scopine salts and their use in processes for the preparation of n-demethyl-tiotropium and tiotropium bromide
11/13/2008US20080280871 5-Phenyl-4-Methyl-Thiazol-2-Yl-Amine Derivatives as Inhibitors of Phosphatidylin Ositol 3 Kinase Enzymes (PI13) For Treatment of Inflammatory Diseases
11/13/2008US20080279775 Benztropinamine Analogs as Dopamine Uptake Inhibitors
11/12/2008EP1990341A1 Triazolyl tropane derivatives as CCR5 modulators
11/12/2008EP1989202A1 Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
11/12/2008EP1989185A1 Therapeutic compounds
11/12/2008CN101304997A Bridged N-bicyclic sulfonamido inhibitors of gamma secretase
11/11/2008US7449456 signal transducer and activator of transcription-6 inhibitors; asthma, COPD, respiratory, inflammatory and allergic diseases; compounds have less suppressive effect on immunological functions; 4-[(2,5 -difluorobenzyl) amino]-2-[(4-morpholin-4-ylphenyl)amino]pyrimidine-5 -carboxamide
11/06/2008WO2008132128A2 Synthesis of a pharmaceutically active compound
11/06/2008US20080275079 M3 Muscarinic Acetylcholine Receptor Antagonists
11/05/2008EP1987006A1 Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
11/04/2008US7446114 minimal side effects, improved selectivity, potency, pharmacokinetics, and/or duration of action; 1-isopropyl-2-oxo-1,2-dihydroquinoline-3-carboxylic acid {(1S,3R,5R)-8-[3-(4-methanesulfonylpiperazine-1-sulfonyl)propyl]-8-azabicyclo[3.2.1]oct-3-yl}amide; reduced motility of the gastrointestinal tract
11/04/2008CA2310458C Piperidine derivatives
10/2008
10/30/2008US20080269229 Serotonine, dopamine and norendrenaline receptors; antidepressants, anxiolytic agents, eating disorders; obesity; bipolar; drug abuse; neurodegenerative diseases
10/29/2008EP1984362A1 Process for preparing intermediates to 5-ht4 receptor agonist compounds
10/23/2008WO2008125691A2 Ethers of naphtalene carboxylic acid amides as cancer cure
10/23/2008CA2683049A1 Organic compounds
10/22/2008EP1981847A1 Secondary amines as renin inhibitors
10/22/2008EP1417190B1 Substituted piperazines as modulators of the melanocortin receptor
10/22/2008CN101291931A 9-azabicyclo [3.3.1]nonane derivatives as monoamine reuptake inhibitors
10/22/2008CN100427484C 2-methoxymethyl-3-(3,4-dichlorophenyl)-8-azabicyclo[3.2.1]octane tartrate salts
10/21/2008US7439264 Therapeutic compounds
10/21/2008US7439255 3-Endo)-3-(2-cyano-2,2-diphenylethyl)-8-(cyclohexylmethyl)-8-methyl-8-azoniabicyclo[3.2.1]octane bromide; smooth muscle relaxation; respiratory system disorders: asthma, COPD, chronic bronchitis, chronic bronchiolitis and emphysema
10/16/2008US20080255197 Aminoalkylpyridines; treating HIV infections; antiinflammatory agents; rheumatic diseases; elevating progesator and stem cell count
10/15/2008EP1979318A1 Amido compounds and their use as pharmaceuticals
10/15/2008EP1904492B1 Method for obtaining the pharmaceutically active compound dolasetron, synthesis intermediates thereof and methods for obtaining them
10/15/2008EP1660455B1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
10/15/2008EP1411940B1 Bridged piperidine derivatives as melanocortin receptor agonists
10/14/2008US7435822 Delta and mu opioid receptors modulators, agonist or antagonist; analgesics, immunosuppressants, antiinflammatory agents; 3-(Phenyl-thiophen-3-yl-methylene)-8-aza-bicyclo[3.2.1]octane; ; neurological and psychiatric conditions; drug and alcohol abuse,; gastritis; diarrhea; cardiovascular; respiratory
10/14/2008US7435744 Brain disorders; central nervous system disorders; viricides
10/09/2008US20080249127 Muscarinic Acetylcholine Receptor Antagonists
10/08/2008EP1976828A1 Diamine derivatives as inhibitors of leukotriene a4 hydrolase
10/08/2008EP1569931B1 Heterocyclic compounds as ccr5 antagonists
10/07/2008US7432376 3-(Phenyl- or naphthyl)-2-(alpha-hydroxyalkyl)- or 2-(alpha-formyloxyalkyl- or alpha-alkanoyloxyalkyl)-nortropanes; for alleviating symptoms of central nervous system disorders
10/02/2008WO2008117871A1 Nitrogen-containing redox catalyst
10/02/2008WO2008117282A1 Polymorph of granisetron base and production process therefor
10/02/2008WO2008117229A1 Muscarinic receptor antagonists
10/01/2008EP1973905A1 Compounds
10/01/2008CN101277955A Cyclic amine compound and pest control agent
10/01/2008CN101277954A 8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
09/2008
09/30/2008US7429601 Tropan-6exo-yl benzilate methobromide or a physiologically acceptable salt or derivative; chronic obstructive pulmonary disease, asthma; urogenital disorders; antihistamine, antispasmodic, and bronchodilator agents
09/30/2008US7429600 Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments
09/25/2008US20080234320 Curcumin analogs with anti-tumor and anti-angiogenic properties
09/25/2008US20080234315 3-Endo)-3-[2,2-Bis-(3-hydroxy-phenyl)-ethenyl]-8,8-dimethyl-8-azonia-bicyclo[3.2.1]octane bromide; chronic obstructive lung disease, chronic bronchitis, asthma, chronic respiratory obstruction, pulmonary fibrosis, pulmonary emphysema, allergic rhinitis
09/25/2008US20080234311 IMMUNOASSAY FOR DETECTION AND QUANTIFICATION OF AMYLOID-beta PEPTIDES
09/24/2008EP1972626A2 Process for producing scopine esters
09/17/2008EP1409477B1 Piperidine derivatives as nmda receptor antagonists
09/17/2008CN101267820A Novel azabicyclo[3.2.1]oct-2-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
09/17/2008CN100418963C Novel herbicides
09/10/2008EP1966200A1 Heterocyclic janus kinase 3 inhibitors
09/10/2008EP1966196A2 Pure and stable tiotropium bromide
09/10/2008EP1966165A1 Pyrazine derivatives as epithelial sodium channel blocker
09/10/2008EP1438053B1 Pyrimidine derivatives, pharmaceutical agent containing said compounds, use and method for making same
09/10/2008CN101263139A Isoxazolo derivatives as GABA A alpha5 inverse agonists
09/09/2008US7423030 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
09/04/2008WO2008106442A1 Synthesis of [18f] fluoromethyl benzene using benzyl pentafluorobenzenesulfonate
09/04/2008WO2008106159A1 Crystalline forms of an 8-azabicyclo[3.2.1]octane compound
09/04/2008WO2008104955A1 Azoniatricyclo [3.3.1.0] nonane derivatives as muscarinic receptor antagonists
09/04/2008WO2008104584A1 Hydrochloride salt of an azabicyclo[3.2.1]octane derivative
09/04/2008CA2679655A1 Hydrochloride salt of an azabicyclo[3.2.1]octane derivative
09/04/2008CA2678073A1 Crystalline forms of an 8-azabicyclo[3.2.1]octane compound
09/03/2008CN100415742C Novel hydrochloride compound and use thereof
09/02/2008CA2395037C The use of scopolamine salts
08/2008
08/28/2008WO2008101979A1 Quinoxaline compounds and use thereof
08/28/2008WO2008101728A1 Method for producing azoniaspironortropine esters and nortropan-3-one compounds
08/28/2008US20080207665 Alpha-(Aryl-or Heteroaryl-Methyl)-Beta-Piperidinopropanoic Acid Compounds as Orl-1-Receptor Antagonists
08/28/2008CA2675884A1 Quinoxaline compounds and use thereof
08/27/2008EP1960396A2 Carbamate compounds as 5-ht4 receptor agonists
08/27/2008EP1960383A1 5-substituted indole-2-carboxamide derivatives
08/27/2008EP1960347A2 17-beta-hydroxysteroid dehydrogenase type 3 (17beta-hsd3) inhibitors
08/27/2008CN100413860C Piperidine derivative as NMDA receptor antagonist
08/26/2008US7417145 Process for total synthesis of ecteinascidins and intermediates therefor
08/26/2008US7417051 9,9-dimethyl-3-oxa-9-azoniumtricyclo(3.3.1.0(2,4))nonanyl 2,2-diphenylpropionate quaternary salt
08/21/2008WO2007081889A8 Production of dolasetron
08/20/2008EP1957493A1 8-azabicyclo[3.2.1]octane derivatives useful as monoamine reuptake inhibitors
08/20/2008EP1957451A1 Soft anticholinergic zwitterions
08/20/2008EP1675851B1 Method for producing n-substituted 3beta-aminonortropanes
08/20/2008EP1569647B1 Cyclohexyl compounds as ccr5 antagonists
08/20/2008CN101248069A Androgen receptor modulators and method of treating disease using the same
08/19/2008CA2257448C Pyridyl alkene- and pyridyl alkine-acid amides as cytostatics and immunosuppressives
08/14/2008WO2008095821A1 Indol-2-yl-piperazin-1-yl-methanone derivatives
08/14/2008WO2007081890A8 Production of dolasetron
08/14/2008US20080194824 Method For Obtaining A Pharmaceutically Active Compound, Synthesis Intermediates Thereof And Methods For Obtaining Them
08/14/2008US20080194618 Muscle relaxants; respiratory system disorders; asthma; COPD; emphysema; bronchitis
08/14/2008CA2676265A1 Indol-2-yl-piperazin-1-yl-methanone derivatives
08/13/2008EP1467993B1 Method for producing scopine esters
08/13/2008CN101243079A Tricyclic opioid modulators
08/13/2008CN100410254C Preparation process of thiatro bromoaminium anhydrous compound
08/13/2008CN100410250C Spiroheterocyclic compoundsus reversible inhibitors of cysteine proteases
08/12/2008US7410969 Antitumoral analogs of ET-743
08/12/2008US7410961 2,6-disubstituted piperiddines as modulators
08/07/2008WO2008092833A1 Method for producing scopinium salts
08/07/2008WO2008092832A1 Method for producing ammonium hexafluorophosphates
08/07/2008WO2008058096A3 Azaadamantane derivatives and their uses as nicotinic acetylcholine receptors ligands
08/07/2008US20080188519 Novel azacyclic ethynyl derivatives
08/07/2008CA2676165A1 Method for producing scopinium salts
08/07/2008CA2676162A1 Method for producing ammonium hexafluorophosphates
08/06/2008EP1953160A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as CRF antagonists
08/06/2008EP1953156A1 Method for manufacturing scopinium salts
1 ... 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 ... 53